Topiramate add‐on therapy for drug‐resistant focal epilepsy

Updated review (12 trials; n=1650) found topiramate has efficacy as an add‐on therapy in this setting as it is almost three times more effective compared to a placebo in reducing seizures, but trials were of relatively short duration and provided no evidence long‐term efficacy.


Cochrane Database of Systematic Reviews